Pathogenesis of Leigh's encephalomyelopathy.
D001933:Brain Stem / Q000201:enzymology*; D004678:Encephalomalacia / Q000188:drug therapy / Q000201:enzymology*; D005260:Female; D005943:Gluconeogenesis; D005973:Glutamine / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008607:Intellectual Disability / Q000188:drug therapy / Q000201:enzymology; D008025:Ligases / Q000378:metabolism; D008930:Mitochondria, Liver / Q000201:enzymology; D010071:Oxaloacetates / Q000378:metabolism; D011596:Psychomotor Disorders / Q000188:drug therapy / Q000201:enzymology; D011736:Pyridoxine / Q000627:therapeutic use
D010071:Oxaloacetates; D005973:Glutamine; D008025:Ligases; D011736:Pyridoxine